Cargando…

Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents

The encapsulated fungus Cryptococcus neoformans is the most common cause of fungal meningitis, with the highest rate of disease in patients with AIDS or immunosuppression. This microbe enters the human body via inhalation of infectious particles. C. neoformans capsular polysaccharide, in which the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hiu Ham, Carmichael, Dylan J., Ríbeiro, Victoria, Parisi, Dana N., Munzen, Melissa E., Charles-Niño, Claudia L., Hamed, Mohamed F., Kaur, Ettiman, Mishra, Ayush, Patel, Jiya, Rooklin, Rikki B., Sher, Amina, Carrillo-Sepulveda, Maria A., Eugenin, Eliseo A., Dores, Michael R., Martinez, Luis R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171644/ https://www.ncbi.nlm.nih.gov/pubmed/37115795 http://dx.doi.org/10.1371/journal.ppat.1010941

Ejemplares similares

Dectin-3 Recognizes Glucuronoxylomannan of Cryptococcus neoformans Serotype AD and Cryptococcus gattii Serotype B to Initiate Host Defense Against Cryptococcosis
por: Huang, Hua-Rong, et al.
Publicado: (2018)

Cryptococcus neoformans Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model
por: Colombo, Ana Caroline, et al.
Publicado: (2019)

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization
Publicado: (1993)

Histoplasma capsulatum Glycans From Distinct Genotypes Share Structural and Serological Similarities to Cryptococcus neoformans Glucuronoxylomannan
por: Gonçalves, Diego de Souza, et al.
Publicado: (2021)

Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis
por: Gibson, Josie F., et al.
Publicado: (2015)

Cryptococcus neoformans–Specific and Non–Cryptococcus neoformans–Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis
por: Yoon, Hyunah, et al.
Publicado: (2022)

A synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes
por: Guazzelli, Lorenzo, et al.
Publicado: (2020)

Old Cryptococcus neoformans Cells Contribute to Virulence in Chronic Cryptococcosis
por: Bouklas, Tejas, et al.
Publicado: (2013)

A Case of Pulmonary Cryptococcosis by Capsule-deficient Cryptococcus neoformans
por: Cheon, Won Seok, et al.
Publicado: (2006)

Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System
por: Hamed, Mohamed F., et al.
Publicado: (2023)

Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan
por: Yauch, Lauren E, et al.
Publicado: (2006)

Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation
por: Desnos-Ollivier, Marie, et al.
Publicado: (2015)

First case of feline cryptococcosis in Hong Kong, caused by Cryptococcus neoformans
por: Almendros, Angel, et al.
Publicado: (2020)

A Case of Pulmonary Cryptococcosis Caused by Capsule-Deficient Cryptococcus neoformans
por: Wolfenbarger, Brandol, et al.
Publicado: (2023)

Interaction of triosephosphate isomerase from the cell surface of Staphylococcus aureus and α-(1→3)-mannooligosaccharides derived from glucuronoxylomannan of Cryptococcus neoformans
por: Furuya, Hiromi, et al.
Publicado: (2009)

Cryptococcosis by Cryptococcus neoformans/Cryptococcus gattii Species Complexes in non-HIV-Infected Patients in Southeastern Brazil
por: Nascimento, Erika, et al.
Publicado: (2021)

The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital
por: de Aguiar, Paula Augusta Dias Fogaça, et al.
Publicado: (2017)

Methamphetamine Enhances Cryptococcus neoformans Pulmonary Infection and Dissemination to the Brain
por: Patel, Dhavan, et al.
Publicado: (2013)

Cryptococcosis and Cryptococcus
por: Francisco, Elaine Cristina, et al.
Publicado: (2021)

Insight into the Assembling Mechanism of Cryptococcus Capsular Glucuronoxylomannan Based on Molecular Dynamics Simulations
por: Fu, Yankai, et al.
Publicado: (2020)

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo
por: Munzen, Melissa E., et al.
Publicado: (2023)

The Crucial Role of Biofilms in Cryptococcus neoformans Survival within Macrophages and Colonization of the Central Nervous System
por: Aslanyan, Lilit, et al.
Publicado: (2017)

Differences in Nitrogen Metabolism between Cryptococcus neoformans and C. gattii, the Two Etiologic Agents of Cryptococcosis
por: Ngamskulrungroj, Popchai, et al.
Publicado: (2012)

P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia
por: Becerra-Alvarez, Paola, et al.
Publicado: (2022)

TNF-α-Producing Cryptococcus neoformans Exerts Protective Effects on Host Defenses in Murine Pulmonary Cryptococcosis
por: Fa, Zhenzong, et al.
Publicado: (2019)

Cryptococcus neoformans VNII as the Main Cause of Cryptococcosis in Domestic Cats from Rio de Janeiro, Brazil
por: Reis, Rosani Santos, et al.
Publicado: (2021)

Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure
por: Urai, Makoto, et al.
Publicado: (2016)

Recent Advances in Cryptococcus and Cryptococcosis
por: Firacative, Carolina, et al.
Publicado: (2021)

Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination
por: Coelho, Carolina, et al.
Publicado: (2019)

Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis
por: Wozniak, Karen L., et al.
Publicado: (2009)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study
por: Chen, Yi-Chun, et al.
Publicado: (2015)

Primary Cutaneous Cryptococcosis due to Cryptococcus neoformans in an Immunocompetent Host Treated with Itraconazole and Drainage: Case Report and Review of the Literature
por: Gaviria Morales, Elizabeth, et al.
Publicado: (2021)

FKS1 Is Required for Cryptococcus neoformans Fitness In Vivo: Application of Copper-Regulated Gene Expression to Mouse Models of Cryptococcosis
por: Beattie, Sarah R., et al.
Publicado: (2022)

A Novel, Inexpensive In-House Immunochromatographic Strip Test for Cryptococcosis Based on the Cryptococcal Glucuronoxylomannan Specific Monoclonal Antibody 18B7
por: Sathongdejwisit, Pakornswit, et al.
Publicado: (2021)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the Cryptococcus neoformans Complex in Jiangxi Province, South Central China
por: Yang, Chunxi, et al.
Publicado: (2021)

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1
por: Normile, Tyler G., et al.
Publicado: (2022)

Environmental Status of Cryptococcus neoformans and Cryptococcus gattii in Colombia
por: Serna-Espinosa, Briggith-Nathalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5m22a7ia6ibgpip4r1o3iukmpm